Search
Summit Therapeutics Inc
SMMTAdd to Watchlist
15.420USD
+1.040+7.23%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
11.97BMarket Cap
LossP/E TTM
Summit Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Summit Therapeutics Inc is 8.48, ranking 127 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.62, which is -398.80% below the recent high of 28.75 and -3037.14% above the recent low of -301.80.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.